2014
DOI: 10.1002/cbic.201402421
|View full text |Cite
|
Sign up to set email alerts
|

Active Site Targeting of Hedgehog Precursor Protein with Phenylarsine Oxide

Abstract: Hedgehog proteins, signaling molecules implicated in human embryo development and cancer, can be inhibited at the stage of autoprocessing by the trivalent arsenical phenyl arsine oxide (PhAsIII). The interaction (apparent Ki, 4×10−7M) is characterized by an optical binding assay and by NMR spectroscopy. PhAsIII appears to be the first validated inhibitor of hedgehog autoprocessing, which is unique to hedgehog proteins and essential for biological activity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
33
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 16 publications
(35 citation statements)
references
References 22 publications
0
33
2
Order By: Relevance
“…No evidence for decomposition of C-H-Y in the presence of ST044643 was found by SDS-PAGE analysis ( Supporting Figure 6B ). We have observed similar quenching behavior with C-H-Y in the presence of phenylarsine oxide, an active-site covalent inhibitor of cholesterolysis [24]. To explore the specificity of this effect, ST044643 was added to the control construct, C-Y, in which the HhC segment is replaced with a glycine-serine linker; no significant change in the FRET ratio of C-Y was apparent with added ST044643 (p= 0.276, n= 15) ( Supporting Figure 6C ).…”
mentioning
confidence: 76%
See 2 more Smart Citations
“…No evidence for decomposition of C-H-Y in the presence of ST044643 was found by SDS-PAGE analysis ( Supporting Figure 6B ). We have observed similar quenching behavior with C-H-Y in the presence of phenylarsine oxide, an active-site covalent inhibitor of cholesterolysis [24]. To explore the specificity of this effect, ST044643 was added to the control construct, C-Y, in which the HhC segment is replaced with a glycine-serine linker; no significant change in the FRET ratio of C-Y was apparent with added ST044643 (p= 0.276, n= 15) ( Supporting Figure 6C ).…”
mentioning
confidence: 76%
“…The key construct, termed C - H - Y , has cyan ( C ) and yellow ( Y ) fluorescent proteins [23] fused to the amino and carboxyl termini of H hC. Recently we reported that C-H-Y could be used to detect binding of HhC by an irreversible inhibitor of cholesterolysis [24]. Here we pursue the expectation that cholesterolysis of C-H-Y will yield cholesterol-modified CFP and HhC-YFP, with a relatively large change in the FRET ratio (i.e.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…We used a construct composed of human HhN and Drosophila HhC as the precursor (SHhN-DHhC) (Fig. 1B), which has been previously used to characterize inhibitors of Hh autoprocessing (28). The autoprocessing reaction was carried out at pH 7.1, the physiologic pH in endoplasmic reticulum where Hh autoprocessing occurs (29).…”
Section: Zinc Inhibits Hh Autoprocessingmentioning
confidence: 99%
“…14 These include cyclopamine 15 and vismodegib 16 , which correspond to the archetypal member and the first FDA-approved drug, respectively, belonging to this class of Hh pathway antagonists. Compounds that target downstream components of this pathway 14 or processes involved in Shh maturation 17 have also been reported. In stark contrast, potent inhibitors of the Shh/Patched protein-protein interaction have remained elusive.…”
mentioning
confidence: 99%